增强IL36RN表达及其与免疫微环境的关联预测胃癌的预后不佳
Xiaojing Zhang1,2, Sutian Jiang3, Hang Yin1
1Clinical and Translational Research Center, Affiliated Hospital of Nantong University and Medical School of Nantong University, Nantong, Jiangsu, China.
Cancer medicine
|May 10, 2025
概括
介素-36受体对手 (IL36RN) 在胃癌 (GC) 中被上调,促进瘤生长和入侵. 向IL36RN可能为GC治疗和免疫治疗提供新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 胃癌 (GC) 是一个重要的全球健康挑战,需要新的治疗目标.
- 了解瘤微环境 (TME) 对改善GC患者的治疗结果至关重要.
研究的目的:
- 研究IL36RN在胃癌中的作用.
- 在GC中评估IL36RN作为预后生物标志物和治疗点.
主要方法:
- 使用癌症基因组图谱 (TCGA) 数据集对GC组织中IL36RNmRNA表达的分析.
- 生物信息学,细胞模型和组织微阵列被用来研究IL36RN功能和TME相互作用.
- 功能性测试评估了IL36RN沉默对GC细胞行为的影响.
主要成果:
- 与正常组织相比,GC组织中的IL36RN表达显著更高.
- 上调的IL36RN与GC患者的生存结果较差相关.
- 抑制IL36RN抑制了GC细胞的增殖和入侵.
- 升高的IL36RN水平与TME中CD8+T细胞透率的增加有关.
- 在GC中,IL36RN独立预测了预后.
结论:
- IL36RN是胃癌的潜在预后生物标志物.
- IL36RN代表了对GC精密瘤学和免疫治疗的有前途的治疗标.
相关概念视频
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...